Pimilprost
Pimilprost
Pimilprost is a synthetic prostaglandin analog that has been studied for its potential therapeutic effects in various medical conditions. Prostaglandins are a group of physiologically active lipid compounds having diverse hormone-like effects in animals. Pimilprost, like other prostaglandin analogs, is designed to mimic the effects of naturally occurring prostaglandins in the body.
Chemical Structure and Properties[edit | edit source]
Pimilprost is a derivative of the prostaglandin E series, specifically designed to enhance certain pharmacological properties while reducing side effects. The chemical structure of Pimilprost includes modifications that increase its stability and bioavailability compared to natural prostaglandins.
Mechanism of Action[edit | edit source]
Pimilprost exerts its effects by binding to specific prostaglandin receptors on the surface of target cells. These receptors are part of the G-protein coupled receptor family and are involved in various signaling pathways. Upon binding, Pimilprost activates intracellular signaling cascades that lead to its therapeutic effects, such as vasodilation, inhibition of platelet aggregation, and modulation of inflammatory responses.
Therapeutic Uses[edit | edit source]
Pimilprost has been investigated for use in several medical conditions, including:
- Peripheral Vascular Disease: Due to its vasodilatory effects, Pimilprost may improve blood flow in patients with peripheral vascular disease.
- Pulmonary Hypertension: The drug's ability to dilate blood vessels can help reduce pulmonary arterial pressure.
- Gastrointestinal Disorders: Pimilprost may protect the gastric mucosa and reduce the risk of ulcers by enhancing mucosal blood flow and inhibiting gastric acid secretion.
Side Effects[edit | edit source]
As with other prostaglandin analogs, Pimilprost may cause side effects such as:
- Headache
- Nausea
- Diarrhea
- Flushing
- Hypotension
These side effects are generally related to its vasodilatory and smooth muscle relaxing properties.
Research and Development[edit | edit source]
Pimilprost is still under investigation in clinical trials to better understand its efficacy and safety profile. Ongoing research aims to optimize its therapeutic potential while minimizing adverse effects.
Also see[edit | edit source]
- Prostaglandin
- Vasodilation
- Peripheral Vascular Disease
- Pulmonary Hypertension
- Gastrointestinal Disorders
Drug groups | Encyclopedia | Dictionary | Cancer drugs | OTC | Alternative meds | Drugs | Medications A-Z | FDA approved products | Portal:Pharmacology
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD